PortfoliosLab logo

BioCryst Pharmaceuticals, Inc. (BCRX)

Equity · Currency in USD · Last updated Mar 18, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in BioCryst Pharmaceuticals, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $12,462 for a total return of roughly 24.62%. All prices are adjusted for splits and dividends.

BCRX (BioCryst Pharmaceuticals, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BCRX

BioCryst Pharmaceuticals, Inc.


BioCryst Pharmaceuticals, Inc. had a return of -29.44% year-to-date (YTD) and -47.64% in the last 12 months. Over the past 10 years, BioCryst Pharmaceuticals, Inc. had an annualized return of 19.82%, outperforming the S&P 500 benchmark which had an annualized return of 9.71%.

1 month-21.66%-5.31%
6 months-36.87%0.39%
1 year-47.64%-10.12%
5 years (annualized)8.58%7.32%
10 years (annualized)19.82%9.71%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current BioCryst Pharmaceuticals, Inc. Sharpe ratio is -0.64. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

BCRX (BioCryst Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Dividend History

BioCryst Pharmaceuticals, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

BCRX (BioCryst Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the BioCryst Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the BioCryst Pharmaceuticals, Inc. is 97.74%, recorded on Jul 3, 2002. The portfolio has not recovered from it yet.



To Bottom


To Recover



-97.74%Aug 28, 2000462Jul 3, 2002
-75.99%Jun 19, 1996581Oct 7, 1998212Aug 11, 1999793
-50.76%Mar 9, 200028Apr 17, 200074Aug 2, 2000102
-47.17%Mar 11, 199428Apr 20, 1994222Mar 13, 1995250
-40.78%Jun 19, 19952Jun 20, 1995209Apr 18, 1996211
-35.94%Aug 25, 199973Dec 7, 199960Mar 3, 2000133
-22.41%Apr 22, 199613May 8, 199611May 23, 199624
-16.67%Mar 23, 199536May 12, 199512May 31, 199548
-8.82%May 24, 19962May 28, 19964Jun 3, 19966
-8.77%Aug 18, 19991Aug 18, 19994Aug 24, 19995

Volatility Chart

Current BioCryst Pharmaceuticals, Inc. volatility is 26.75%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

BCRX (BioCryst Pharmaceuticals, Inc.)
Benchmark (^GSPC)